Obinutuzumab: Solution for I.V. infusion, 1000 mg in 40 mL; GAZYVA®
Page last updated: 9 November 2018
Public Summary Document (PSD) March 2018 PBAC Meeting - (PDF 135 KB)
Public Summary Document (PSD) March 2018 PBAC Meeting - (Word 42 KB)